ArticleScientific reports2023

CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.

Pina Ziranu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.